Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver...
Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
About this item
Full title
Author / Creator
Publisher
Poznan: Termedia Publishing House
Journal title
Language
English
Formats
Publication information
Publisher
Poznan: Termedia Publishing House
Subjects
More information
Scope and Contents
Contents
Purpose Sarcopenia has been identified as a prognostic marker of clinical outcomes in several diseases. However, the influence of sarcopenia on non-surgical local treatments in breast cancer liver metastases (BCLM) is unknown. Therefore, the purpose of this study was to assess the effect of sarcopenia among patients with BCLM undergoing interstitia...
Alternative Titles
Full title
Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2723821844
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2723821844
Other Identifiers
ISSN
1689-832X
E-ISSN
2081-2841
DOI
10.5114/jcb.2022.119515
